Global and United States Targeted DNA/RNA Sequencing Market Size, Status and Forecast 2020-2026
1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Targeted DNA/RNA Sequencing Market Size Growth Rate by Type: 2020 VS 2026
- 1.2.2 DNA-based Targeted Sequencing
- 1.2.3 RNA-based Targeted Sequencing
- 1.3 Market by Application
- 1.3.1 Global Targeted DNA/RNA Sequencing Market Share by Application: 2020 VS 2026
- 1.3.2 Human Biomedical Research
- 1.3.3 Plant & Animal Sciences
- 1.3.4 Drug Discovery
- 1.3.5 Others
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Targeted DNA/RNA Sequencing Market Perspective (2015-2026)
- 2.2 Global Targeted DNA/RNA Sequencing Growth Trends by Regions
- 2.2.1 Targeted DNA/RNA Sequencing Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Targeted DNA/RNA Sequencing Historic Market Share by Regions (2015-2020)
- 2.2.3 Targeted DNA/RNA Sequencing Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Targeted DNA/RNA Sequencing Players by Market Size
- 3.1.1 Global Top Targeted DNA/RNA Sequencing Players by Revenue (2015-2020)
- 3.1.2 Global Targeted DNA/RNA Sequencing Revenue Market Share by Players (2015-2020)
- 3.2 Global Targeted DNA/RNA Sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Players Covered: Ranking by Targeted DNA/RNA Sequencing Revenue
- 3.4 Global Targeted DNA/RNA Sequencing Market Concentration Ratio
- 3.4.1 Global Targeted DNA/RNA Sequencing Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Targeted DNA/RNA Sequencing Revenue in 2019
- 3.5 Key Players Targeted DNA/RNA Sequencing Area Served
- 3.6 Key Players Targeted DNA/RNA Sequencing Product Solution and Service
- 3.7 Date of Enter into Targeted DNA/RNA Sequencing Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Targeted DNA/RNA Sequencing Breakdown Data by Type (2015-2026)
- 4.1 Global Targeted DNA/RNA Sequencing Historic Market Size by Type (2015-2020)
- 4.2 Global Targeted DNA/RNA Sequencing Forecasted Market Size by Type (2021-2026)
5 Targeted DNA/RNA Sequencing Breakdown Data by Application (2015-2026)
- 5.1 Global Targeted DNA/RNA Sequencing Historic Market Size by Application (2015-2020)
- 5.2 Global Targeted DNA/RNA Sequencing Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Targeted DNA/RNA Sequencing Market Size (2015-2026)
- 6.2 North America Targeted DNA/RNA Sequencing Market Size by Type (2015-2020)
- 6.3 North America Targeted DNA/RNA Sequencing Market Size by Application (2015-2020)
- 6.4 North America Targeted DNA/RNA Sequencing Market Size by Country (2015-2020)
- 6.4.1 United States
- 6.4.2 Canada
7 Europe
- 7.1 Europe Targeted DNA/RNA Sequencing Market Size (2015-2026)
- 7.2 Europe Targeted DNA/RNA Sequencing Market Size by Type (2015-2020)
- 7.3 Europe Targeted DNA/RNA Sequencing Market Size by Application (2015-2020)
- 7.4 Europe Targeted DNA/RNA Sequencing Market Size by Country (2015-2020)
- 7.4.1 Germany
- 7.4.2 France
- 7.4.3 U.K.
- 7.4.4 Italy
- 7.4.5 Russia
- 7.4.6 Nordic
- 7.4.7 Rest of Europe
8 China
- 8.1 China Targeted DNA/RNA Sequencing Market Size (2015-2026)
- 8.2 China Targeted DNA/RNA Sequencing Market Size by Type (2015-2020)
- 8.3 China Targeted DNA/RNA Sequencing Market Size by Application (2015-2020)
- 8.4 China Targeted DNA/RNA Sequencing Market Size by Region (2015-2020)
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 South Korea
- 8.4.4 Southeast Asia
- 8.4.5 India
- 8.4.6 Australia
- 8.4.7 Rest of Asia-Pacific
9 Japan
- 9.1 Japan Targeted DNA/RNA Sequencing Market Size (2015-2026)
- 9.2 Japan Targeted DNA/RNA Sequencing Market Size by Type (2015-2020)
- 9.3 Japan Targeted DNA/RNA Sequencing Market Size by Application (2015-2020)
- 9.4 Japan Targeted DNA/RNA Sequencing Market Size by Country (2015-2020)
- 9.4.1 Mexico
- 9.4.2 Brazil
10 Southeast Asia
- 10.1 Southeast Asia Targeted DNA/RNA Sequencing Market Size (2015-2026)
- 10.2 Southeast Asia Targeted DNA/RNA Sequencing Market Size by Type (2015-2020)
- 10.3 Southeast Asia Targeted DNA/RNA Sequencing Market Size by Application (2015-2020)
- 10.4 Southeast Asia Targeted DNA/RNA Sequencing Market Size by Country (2015-2020)
- 10.4.1 Turkey
- 10.4.2 Saudi Arabia
- 10.4.3 UAE
- 10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
- 11.1 Illumina, Inc.
- 11.1.1 Illumina, Inc. Company Details
- 11.1.2 Illumina, Inc. Business Overview
- 11.1.3 Illumina, Inc. Targeted DNA/RNA Sequencing Introduction
- 11.1.4 Illumina, Inc. Revenue in Targeted DNA/RNA Sequencing Business (2015-2020))
- 11.1.5 Illumina, Inc. Recent Development
- 11.2 F. Hoffmann-La Roche Ltd
- 11.2.1 F. Hoffmann-La Roche Ltd Company Details
- 11.2.2 F. Hoffmann-La Roche Ltd Business Overview
- 11.2.3 F. Hoffmann-La Roche Ltd Targeted DNA/RNA Sequencing Introduction
- 11.2.4 F. Hoffmann-La Roche Ltd Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
- 11.2.5 F. Hoffmann-La Roche Ltd Recent Development
- 11.3 Agilent Technologies
- 11.3.1 Agilent Technologies Company Details
- 11.3.2 Agilent Technologies Business Overview
- 11.3.3 Agilent Technologies Targeted DNA/RNA Sequencing Introduction
- 11.3.4 Agilent Technologies Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
- 11.3.5 Agilent Technologies Recent Development
- 11.4 GATC Biotech Ag
- 11.4.1 GATC Biotech Ag Company Details
- 11.4.2 GATC Biotech Ag Business Overview
- 11.4.3 GATC Biotech Ag Targeted DNA/RNA Sequencing Introduction
- 11.4.4 GATC Biotech Ag Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
- 11.4.5 GATC Biotech Ag Recent Development
- 11.5 Oxford Nanopore Technologies
- 11.5.1 Oxford Nanopore Technologies Company Details
- 11.5.2 Oxford Nanopore Technologies Business Overview
- 11.5.3 Oxford Nanopore Technologies Targeted DNA/RNA Sequencing Introduction
- 11.5.4 Oxford Nanopore Technologies Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
- 11.5.5 Oxford Nanopore Technologies Recent Development
- 11.6 Thermo Fisher Scientific, Inc.
- 11.6.1 Thermo Fisher Scientific, Inc. Company Details
- 11.6.2 Thermo Fisher Scientific, Inc. Business Overview
- 11.6.3 Thermo Fisher Scientific, Inc. Targeted DNA/RNA Sequencing Introduction
- 11.6.4 Thermo Fisher Scientific, Inc. Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
- 11.6.5 Thermo Fisher Scientific, Inc. Recent Development
- 11.7 DNASTAR Inc.
- 11.7.1 DNASTAR Inc. Company Details
- 11.7.2 DNASTAR Inc. Business Overview
- 11.7.3 DNASTAR Inc. Targeted DNA/RNA Sequencing Introduction
- 11.7.4 DNASTAR Inc. Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
- 11.7.5 DNASTAR Inc. Recent Development
- 11.8 QIAGEN
- 11.8.1 QIAGEN Company Details
- 11.8.2 QIAGEN Business Overview
- 11.8.3 QIAGEN Targeted DNA/RNA Sequencing Introduction
- 11.8.4 QIAGEN Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
- 11.8.5 QIAGEN Recent Development
- 11.9 BGI
- 11.9.1 BGI Company Details
- 11.9.2 BGI Business Overview
- 11.9.3 BGI Targeted DNA/RNA Sequencing Introduction
- 11.9.4 BGI Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
- 11.9.5 BGI Recent Development
- 11.10 Perkin Elmer, Inc.
- 11.10.1 Perkin Elmer, Inc. Company Details
- 11.10.2 Perkin Elmer, Inc. Business Overview
- 11.10.3 Perkin Elmer, Inc. Targeted DNA/RNA Sequencing Introduction
- 11.10.4 Perkin Elmer, Inc. Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
- 11.10.5 Perkin Elmer, Inc. Recent Development
- 11.11 Pacific Biosciences of California, Inc.
- 10.11.1 Pacific Biosciences of California, Inc. Company Details
- 10.11.2 Pacific Biosciences of California, Inc. Business Overview
- 10.11.3 Pacific Biosciences of California, Inc. Targeted DNA/RNA Sequencing Introduction
- 10.11.4 Pacific Biosciences of California, Inc. Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
- 10.11.5 Pacific Biosciences of California, Inc. Recent Development
- 11.12 Bio-Rad Laboratories, Inc.
- 10.12.1 Bio-Rad Laboratories, Inc. Company Details
- 10.12.2 Bio-Rad Laboratories, Inc. Business Overview
- 10.12.3 Bio-Rad Laboratories, Inc. Targeted DNA/RNA Sequencing Introduction
- 10.12.4 Bio-Rad Laboratories, Inc. Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
- 10.12.5 Bio-Rad Laboratories, Inc. Recent Development
- 11.13 Integrated DNA Technologies, Inc.
- 10.13.1 Integrated DNA Technologies, Inc. Company Details
- 10.13.2 Integrated DNA Technologies, Inc. Business Overview
- 10.13.3 Integrated DNA Technologies, Inc. Targeted DNA/RNA Sequencing Introduction
- 10.13.4 Integrated DNA Technologies, Inc. Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
- 10.13.5 Integrated DNA Technologies, Inc. Recent Development
- 11.14 RainDance Technologies, Inc.
- 10.14.1 RainDance Technologies, Inc. Company Details
- 10.14.2 RainDance Technologies, Inc. Business Overview
- 10.14.3 RainDance Technologies, Inc. Targeted DNA/RNA Sequencing Introduction
- 10.14.4 RainDance Technologies, Inc. Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
- 10.14.5 RainDance Technologies, Inc. Recent Development
- 11.15 PierianDx
- 10.15.1 PierianDx Company Details
- 10.15.2 PierianDx Business Overview
- 10.15.3 PierianDx Targeted DNA/RNA Sequencing Introduction
- 10.15.4 PierianDx Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
- 10.15.5 PierianDx Recent Development
- 11.16 Genomatix GmbH
- 10.16.1 Genomatix GmbH Company Details
- 10.16.2 Genomatix GmbH Business Overview
- 10.16.3 Genomatix GmbH Targeted DNA/RNA Sequencing Introduction
- 10.16.4 Genomatix GmbH Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
- 10.16.5 Genomatix GmbH Recent Development
- 11.17 Macrogen, Inc.
- 10.17.1 Macrogen, Inc. Company Details
- 10.17.2 Macrogen, Inc. Business Overview
- 10.17.3 Macrogen, Inc. Targeted DNA/RNA Sequencing Introduction
- 10.17.4 Macrogen, Inc. Revenue in Targeted DNA/RNA Sequencing Business (2015-2020)
- 10.17.5 Macrogen, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Disclaimer
Global Targeted DNA/RNA Sequencing Scope and Market Size
Targeted DNA/RNA Sequencing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Targeted DNA/RNA Sequencing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
DNA-based Targeted Sequencing
RNA-based Targeted Sequencing
Market segment by Application, split into
Human Biomedical Research
Plant & Animal Sciences
Drug Discovery
Others
Based on regional and country-level analysis, the Targeted DNA/RNA Sequencing market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Targeted DNA/RNA Sequencing market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Illumina, Inc.
F. Hoffmann-La Roche Ltd
Agilent Technologies
GATC Biotech Ag
Oxford Nanopore Technologies
Thermo Fisher Scientific, Inc.
DNASTAR Inc.
QIAGEN
BGI
Perkin Elmer, Inc.
Pacific Biosciences of California, Inc.
Bio-Rad Laboratories, Inc.
Integrated DNA Technologies, Inc.
RainDance Technologies, Inc.
PierianDx
Genomatix GmbH
Macrogen, Inc.